Survival Factors in IDH-Wildtype Glioblastoma: Insights from a Comprehensive Real-World Cohort Study on Clinical, Molecular, and Immunological Aspects Following Radiotherapy - Quiz - MDSpire

Survival Factors in IDH-Wildtype Glioblastoma: Insights from a Comprehensive Real-World Cohort Study on Clinical, Molecular, and Immunological Aspects Following Radiotherapy

  • By

  • Cole Friedes

  • Melanie Berger

  • Lauren Linkowski

  • Casey Hollawell

  • Harper Hubbeling

  • Daniel Alexander

  • Goldie Kurtz

  • Robert A. Lustig

  • Jay F. Dorsey

  • Arati S. Desai

  • Richard E. Phillips

  • Steven Brem

  • Christos Davatzikos

  • MacLean Nasrallah

  • Donald M. O’Rourke

  • Christina Jackson

  • Nduka M. Amankulor

  • Michelle Alonso-Basanta

  • Suyash Mohan

  • Stephen J. Bagley

  • Emily S. Lebow

  • April 25, 2026

  • 0 min

Share

Original Source(s)

Survival Factors in IDH-Wildtype Glioblastoma: Insights from a Comprehensive Real-World Cohort Study on Clinical, Molecular, and Immunological Aspects Following Radiotherapy

  • by Cole Friedes, Melanie Berger, Lauren Linkowski, Casey Hollawell, Harper Hubbeling, Daniel Alexander, Goldie Kurtz, Robert A. Lustig, Jay F. Dorsey, Arati S. Desai, Richard E. Phillips, Steven Brem, Christos Davatzikos, MacLean Nasrallah, Donald M. O’Rourke, Christina Jackson, Nduka M. Amankulor, Michelle Alonso-Basanta, Suyash Mohan, Stephen J. Bagley, Emily S. Lebow

  • April 25, 2026

Related Content

Recurrent IDH-mutant astrocytoma WHO grade 4 diagnosed during pregnancy: case report with literature review

Is full adherence mandatory? Real-world outcomes of completing perioperative chemoimmunotherapy in resectable non-small cell lung cancer

FEBAIR microsurgical principles in meningiomas and recurrence: a long-term follow-up series